15536456

Source:http://linkedlifedata.com/resource/pubmed/id/15536456

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0031444, umls-concept:C0449438, umls-concept:C0608437, umls-concept:C1280500, umls-concept:C1882417, umls-concept:C2917212
pubmed:issue	5
pubmed:dateCreated	2004-11-10
pubmed:abstractText	Our objective was to assess whether there is an association between the presence of allelic variants of the gene for cytochrome P450 (CYP) 2C9 and anticoagulation problems during the initial phase of phenprocoumon treatment.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15536456-15903131
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372741
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases, http://linkedlifedata.com/resource/pubmed/chemical/CYP2C9 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Phenprocoumon
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0009-9236
pubmed:author	pubmed-author:ConemansJeanJ, pubmed-author:HermansMirjamM, pubmed-author:MeijermanIrmaI, pubmed-author:OosterhofMirjamM, pubmed-author:SchalekampTomT, pubmed-author:de BoerAnthoniusA, pubmed-author:van Der MeerFelix J MFJ, pubmed-author:van MeegenErikE
pubmed:issnType	Print
pubmed:volume	76
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	409-17
pubmed:dateRevised	2005-6-2
pubmed:meshHeading	pubmed-meshheading:15536456-Aged, pubmed-meshheading:15536456-Alleles, pubmed-meshheading:15536456-Anticoagulants, pubmed-meshheading:15536456-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:15536456-Blood Coagulation, pubmed-meshheading:15536456-Dose-Response Relationship, Drug, pubmed-meshheading:15536456-Endpoint Determination, pubmed-meshheading:15536456-Female, pubmed-meshheading:15536456-Follow-Up Studies, pubmed-meshheading:15536456-Gene Frequency, pubmed-meshheading:15536456-Genotype, pubmed-meshheading:15536456-Heterozygote, pubmed-meshheading:15536456-Humans, pubmed-meshheading:15536456-Male, pubmed-meshheading:15536456-Middle Aged, pubmed-meshheading:15536456-Netherlands, pubmed-meshheading:15536456-Phenprocoumon, pubmed-meshheading:15536456-Polymorphism, Genetic, pubmed-meshheading:15536456-Proportional Hazards Models, pubmed-meshheading:15536456-Prospective Studies
pubmed:year	2004
pubmed:articleTitle	Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status.
pubmed:affiliation	Department of Pharmacoepidemiology and Pharmacotherapy, University Institute of Pharmaceutical Sciences, Utrecht University, Utrecht. tschalekamp@pharm.uu.nl
pubmed:publicationType	Journal Article